Hostname: page-component-77c89778f8-vsgnj Total loading time: 0 Render date: 2024-07-17T15:13:12.087Z Has data issue: false hasContentIssue false
  • English
  • Français

In defence of clozapine

Published online by Cambridge University Press:  02 January 2018

Robert Kerwin
Robert Kerwin*
Affiliation:
Institute of Psychiatry De Crespigny Park Denmark Hill London SE5 8AF
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 162 , Issue 4 , April 1993 , pp. 566 - 567
Copyright
Copyright © Royal College of Psychiatrists, 1993 

References

Cutting, J. & Reveley, A. M. (1991) Expert opinion: clozapine. Psychiatric Bulletin, 15, 617.CrossRefGoogle Scholar
Kane, J., Honigfeld, G., Singer, J., et al (1988) xClozapine for the treatment resistant schizophrenic. Archives of General Psychiatry, 45, 789–796.Google Scholar
Lancet Editorial. (1992) Lancet, 339, 276–277.Google Scholar
Launer, M. (1991) Experience with clozapine. Psychiatric Bulletin, 15, 223–224.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.